Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2017: 3.022

CiteScore 2017: 2.81

SCImago Journal Rank (SJR) 2017: 1.562
Source Normalized Impact per Paper (SNIP) 2017: 0.705

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 382, Issue 2

Issues

Intra- and Intermolecular Triplex DNA Formation in the Murine c-myb Proto-Oncogene Promoter Are Inhibited by Mithramycin

Nadarajah Vigneswaran / Jeyasakthy Thayaparan / Judy Knops / John Trent / Vladimir Potaman / Donald M. Miller / Wolfgang Zacharias
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.2001.040

Abstract

Mithramycin inhibits transcription by binding to G/Crich sequences, thereby preventing regulatory protein binding. However, it is also possible that mithramycin inhibits gene expression by preventing intramolecular triplex DNA assembly. We tested this hypothesis using the DNA triplex adopted by the murine cmyb protooncogene. The 5regulatory region of cmyb contains two polypurine:polypyrimidine tracts with imperfect mirror symmetry, which are highly conserved in the murine and human cmyb sequences. The DNA binding drugs mithramycin and distamycin bind to one of these regions as determined by DNase I protection assay. Gel mobility shift assays, nuclease and chemical hypersensitivity and 2Dgel topological analyses as well as triplexspecific antibody binding studies confirmed the formation of purine*purine:pyrimidine inter and pyrimidine*purine:pyrimidine intramolecular triplex structures in this sequence. Mithramycin binding within the triplex target site displaces the major groovebound oligonucleotide, and also abrogates the supercoildependent HDNA formation, whereas distamycin binding had no such effects. Molecular modeling studies further support these observations. Triplexspecific antibody staining of cells pretreated with mithramycin demonstrates a reversal of chromosomal triplex structures compared to the nontreated and distamycintreated cells. These observations suggest that DNA minor groovebinding drugs interfere with gene expression by precluding intramolecular triplex formation, as well as by physically preventing regulatory protein binding.

About the article

Published Online: 2005-06-01

Published in Print: 2001-02-12


Citation Information: Biological Chemistry, Volume 382, Issue 2, Pages 329–342, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2001.040.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Amrita Banerjee, Sulagna Sanyal, Kirti K. Kulkarni, Kuladip Jana, Siddhartha Roy, Chandrima Das, and Dipak Dasgupta
FEBS Open Bio, 2014, Volume 4, Number 1, Page 987
[2]
S. Cogoi and L. E. Xodo
Nucleic Acids Research, 2006, Volume 34, Number 9, Page 2536
[3]
Tzi-Peng Yang, Hui-Ling Chiou, Ming-Chei Maa, and Chau-Jong Wang
Chemico-Biological Interactions, 2010, Volume 183, Number 1, Page 181
[4]
Jean-Philippe Brouland, Pascal Gélébart, Tünde Kovàcs, Jocelyne Enouf, Johannes Grossmann, and Béla Papp
The American Journal of Pathology, 2005, Volume 167, Number 1, Page 233
[5]
Saptaparni Ghosh, Parijat Majumder, Suman Kalyan Pradhan, and Dipak Dasgupta
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010, Volume 1799, Number 10-12, Page 795
[6]
Carlos Olano, Carmen Méndez, and José A. Salas
Natural Product Reports, 2009, Volume 26, Number 5, Page 628
[7]
Felipe Lombó, Nuria Menéndez, José A. Salas, and Carmen Méndez
Applied Microbiology and Biotechnology, 2006, Volume 73, Number 1, Page 1

Comments (0)

Please log in or register to comment.
Log in